Annual CFF
$4.28 M
+$4.28 M+100.00%
31 December 2023
Summary:
ZIVO Bioscience annual cash flow from financing activities is currently $4.28 million, with the most recent change of +$4.28 million (+100.00%) on 31 December 2023. During the last 3 years, it has risen by +$1.89 million (+79.61%). ZIVO annual CFF is now -72.54% below its all-time high of $15.57 million, reached on 31 December 2021.ZIVO Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$1.24 M
+$754.50 K+154.77%
30 September 2024
Summary:
ZIVO Bioscience quarterly cash flow from financing activities is currently $1.24 million, with the most recent change of +$754.50 thousand (+154.77%) on 30 September 2024. Over the past year, it has dropped by -$2.19 million (-63.82%). ZIVO quarterly CFF is now -90.24% below its all-time high of $12.72 million, reached on 30 June 2021.ZIVO Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$2.80 M
-$2.19 M-43.91%
30 September 2024
Summary:
ZIVO Bioscience TTM cash flow from financing activities is currently $2.80 million, with the most recent change of -$2.19 million (-43.91%) on 30 September 2024. Over the past year, it has dropped by -$1.83 million (-39.56%). ZIVO TTM CFF is now -83.09% below its all-time high of $16.55 million, reached on 30 September 2021.ZIVO TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZIVO Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +100.0% | -63.8% | -39.6% |
| 3 y3 years | +79.6% | -27.0% | -83.1% |
| 5 y5 years | -15.8% | -4.3% | -29.5% |
ZIVO Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -72.5% | -63.8% | +351.2% | -83.1% | >+9999.0% | |
| 5 y | 5 years | -72.5% | -90.2% | +351.2% | -83.1% | >+9999.0% | |
| alltime | all time | -72.5% | -90.2% | +351.2% | -83.1% | >+9999.0% |
ZIVO Bioscience Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.24 M(+154.8%) | $2.80 M(-43.9%) |
| June 2024 | - | $487.50 K(-68.8%) | $4.99 M(-5.9%) |
| Mar 2024 | - | $1.56 M(-416.2%) | $5.30 M(+24.0%) |
| Dec 2023 | $4.28 M(>+9900.0%) | -$494.50 K(-114.4%) | $4.28 M(-7.7%) |
| Sept 2023 | - | $3.43 M(+330.2%) | $4.63 M(+369.0%) |
| June 2023 | - | $798.10 K(+48.3%) | $987.20 K(-4939.2%) |
| Mar 2023 | - | $538.30 K(-485.3%) | -$20.40 K(<-9900.0%) |
| Dec 2022 | $0.00(-100.0%) | -$139.70 K(-33.3%) | $100.00(-99.9%) |
| Sept 2022 | - | -$209.50 K(0.0%) | $139.80 K(-93.2%) |
| June 2022 | - | -$209.50 K(-137.5%) | $2.05 M(-86.3%) |
| Mar 2022 | - | $558.80 K(>+9900.0%) | $14.98 M(-3.8%) |
| Dec 2021 | $15.57 M(+554.0%) | $0.00(-100.0%) | $15.57 M(-5.9%) |
| Sept 2021 | - | $1.70 M(-86.6%) | $16.55 M(+7.8%) |
| June 2021 | - | $12.72 M(+1009.8%) | $15.35 M(+398.5%) |
| Mar 2021 | - | $1.15 M(+16.5%) | $3.08 M(+29.4%) |
| Dec 2020 | $2.38 M(-35.0%) | $984.00 K(+96.6%) | $2.38 M(+0.1%) |
| Sept 2020 | - | $500.60 K(+11.6%) | $2.38 M(-25.1%) |
| June 2020 | - | $448.60 K(+0.4%) | $3.18 M(-19.0%) |
| Mar 2020 | - | $447.00 K(-54.5%) | $3.92 M(+7.0%) |
| Dec 2019 | $3.66 M(-27.8%) | $982.00 K(-24.3%) | $3.66 M(-7.6%) |
| Sept 2019 | - | $1.30 M(+8.8%) | $3.97 M(+15.0%) |
| June 2019 | - | $1.19 M(+522.6%) | $3.45 M(-25.3%) |
| Mar 2019 | - | $191.60 K(-85.1%) | $4.61 M(-9.1%) |
| Dec 2018 | $5.08 M(+25.3%) | $1.28 M(+64.7%) | $5.08 M(+19.5%) |
| Sept 2018 | - | $780.00 K(-66.9%) | $4.25 M(-27.9%) |
| June 2018 | - | $2.36 M(+260.0%) | $5.90 M(+60.3%) |
| Mar 2018 | - | $655.00 K(+44.0%) | $3.68 M(-9.3%) |
| Dec 2017 | $4.05 M(+33.6%) | $455.00 K(-81.3%) | $4.05 M(-6.6%) |
| Sept 2017 | - | $2.43 M(+1634.3%) | $4.34 M(+49.0%) |
| June 2017 | - | $140.00 K(-86.4%) | $2.91 M(-4.9%) |
| Mar 2017 | - | $1.03 M(+38.9%) | $3.06 M(+1.0%) |
| Dec 2016 | $3.03 M(+31.2%) | $741.60 K(-25.8%) | $3.03 M(+9.3%) |
| Sept 2016 | - | $1.00 M(+243.1%) | $2.78 M(+18.8%) |
| June 2016 | - | $291.50 K(-70.9%) | $2.34 M(-19.5%) |
| Mar 2016 | - | $1.00 M(+107.1%) | $2.90 M(+25.5%) |
| Dec 2015 | $2.31 M(+3.0%) | $483.20 K(-13.7%) | $2.31 M(+14.1%) |
| Sept 2015 | - | $560.00 K(-34.7%) | $2.03 M(-26.4%) |
| June 2015 | - | $857.50 K(+108.4%) | $2.75 M(+16.1%) |
| Mar 2015 | - | $411.40 K(+108.1%) | $2.37 M(+5.7%) |
| Dec 2014 | $2.24 M(-40.4%) | $197.70 K(-84.6%) | $2.24 M(-26.5%) |
| Sept 2014 | - | $1.29 M(+169.6%) | $3.05 M(+5.0%) |
| June 2014 | - | $476.80 K(+67.7%) | $2.91 M(-17.2%) |
| Mar 2014 | - | $284.30 K(-71.8%) | $3.51 M(-6.7%) |
| Dec 2013 | $3.76 M(+135.5%) | $1.01 M(-11.8%) | $3.76 M(+19.3%) |
| Sept 2013 | - | $1.14 M(+5.6%) | $3.15 M(+31.8%) |
| June 2013 | - | $1.08 M(+102.0%) | $2.39 M(+41.4%) |
| Mar 2013 | - | $535.00 K(+34.9%) | $1.69 M(+5.9%) |
| Dec 2012 | $1.60 M | $396.50 K(+4.3%) | $1.60 M(-15.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2012 | - | $380.30 K(-0.0%) | $1.89 M(+4.2%) |
| June 2012 | - | $380.40 K(-13.7%) | $1.81 M(+10.6%) |
| Mar 2012 | - | $441.00 K(-36.0%) | $1.64 M(+8.8%) |
| Dec 2011 | $1.51 M(+1.6%) | $689.20 K(+126.5%) | $1.51 M(+49.6%) |
| Sept 2011 | - | $304.30 K(+47.4%) | $1.01 M(+4.4%) |
| June 2011 | - | $206.50 K(-33.1%) | $965.60 K(+45.2%) |
| Mar 2011 | - | $308.90 K(+63.6%) | $665.10 K(-55.2%) |
| Dec 2010 | $1.49 M(+27.5%) | $188.80 K(-27.8%) | $1.48 M(-1.8%) |
| Sept 2010 | - | $261.40 K(-378.1%) | $1.51 M(-22.2%) |
| June 2010 | - | -$94.00 K(-108.3%) | $1.94 M(-10.9%) |
| Mar 2010 | - | $1.13 M(+421.1%) | $2.18 M(+87.6%) |
| Dec 2009 | $1.16 M(+10.9%) | $216.60 K(-68.8%) | $1.16 M(+14.2%) |
| Sept 2009 | - | $693.50 K(+377.9%) | $1.02 M(+128.0%) |
| June 2009 | - | $145.10 K(+32.9%) | $447.10 K(-37.7%) |
| Mar 2009 | - | $109.20 K(+52.1%) | $717.70 K(-31.7%) |
| Dec 2008 | $1.05 M(-25.3%) | $71.80 K(-40.7%) | $1.05 M(+1.7%) |
| Sept 2008 | - | $121.00 K(-70.9%) | $1.03 M(-25.8%) |
| June 2008 | - | $415.70 K(-6.0%) | $1.39 M(+56.8%) |
| Mar 2008 | - | $442.00 K(+720.0%) | $887.70 K(-36.9%) |
| Dec 2007 | $1.41 M(-13.2%) | $53.90 K(-88.8%) | $1.41 M(-3.4%) |
| Sept 2007 | - | $480.50 K(-641.7%) | $1.46 M(-21.1%) |
| June 2007 | - | -$88.70 K(-109.2%) | $1.84 M(-27.8%) |
| Mar 2007 | - | $960.10 K(+827.6%) | $2.55 M(+57.8%) |
| Dec 2006 | $1.62 M(-28.2%) | $103.50 K(-88.1%) | $1.62 M(-37.7%) |
| Sept 2006 | - | $868.60 K(+39.7%) | $2.60 M(+31.9%) |
| June 2006 | - | $621.90 K(+2428.0%) | $1.97 M(+3.1%) |
| Mar 2006 | - | $24.60 K(-97.7%) | $1.91 M(-15.2%) |
| Dec 2005 | $2.25 M(+70.7%) | $1.08 M(+352.7%) | $2.25 M(+49.8%) |
| Sept 2005 | - | $239.60 K(-57.4%) | $1.50 M(+40.0%) |
| June 2005 | - | $562.60 K(+53.5%) | $1.07 M(-26.2%) |
| Mar 2005 | - | $366.40 K(+9.2%) | $1.46 M(+10.2%) |
| Dec 2004 | $1.32 M(+7114.2%) | $335.40 K(-276.2%) | $1.32 M(+31.6%) |
| Sept 2004 | - | -$190.30 K(-120.2%) | $1.00 M(-15.9%) |
| June 2004 | - | $943.50 K(+307.2%) | $1.19 M(+377.4%) |
| Mar 2004 | - | $231.70 K(+1166.1%) | $250.00 K(+1266.1%) |
| Dec 2003 | $18.30 K(>+9900.0%) | $18.30 K(>+9900.0%) | $18.30 K(>+9900.0%) |
| Sept 2003 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2003 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2003 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2002 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2002 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2002 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2002 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2001 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2001 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2001 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2001 | - | $0.00 | $0.00 |
| Dec 2000 | $0.00 | - | - |
FAQ
- What is ZIVO Bioscience annual cash flow from financing activities?
- What is the all time high annual CFF for ZIVO Bioscience?
- What is ZIVO Bioscience annual CFF year-on-year change?
- What is ZIVO Bioscience quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for ZIVO Bioscience?
- What is ZIVO Bioscience quarterly CFF year-on-year change?
- What is ZIVO Bioscience TTM cash flow from financing activities?
- What is the all time high TTM CFF for ZIVO Bioscience?
- What is ZIVO Bioscience TTM CFF year-on-year change?
What is ZIVO Bioscience annual cash flow from financing activities?
The current annual CFF of ZIVO is $4.28 M
What is the all time high annual CFF for ZIVO Bioscience?
ZIVO Bioscience all-time high annual cash flow from financing activities is $15.57 M
What is ZIVO Bioscience annual CFF year-on-year change?
Over the past year, ZIVO annual cash flow from financing activities has changed by +$4.28 M (+100.00%)
What is ZIVO Bioscience quarterly cash flow from financing activities?
The current quarterly CFF of ZIVO is $1.24 M
What is the all time high quarterly CFF for ZIVO Bioscience?
ZIVO Bioscience all-time high quarterly cash flow from financing activities is $12.72 M
What is ZIVO Bioscience quarterly CFF year-on-year change?
Over the past year, ZIVO quarterly cash flow from financing activities has changed by -$2.19 M (-63.82%)
What is ZIVO Bioscience TTM cash flow from financing activities?
The current TTM CFF of ZIVO is $2.80 M
What is the all time high TTM CFF for ZIVO Bioscience?
ZIVO Bioscience all-time high TTM cash flow from financing activities is $16.55 M
What is ZIVO Bioscience TTM CFF year-on-year change?
Over the past year, ZIVO TTM cash flow from financing activities has changed by -$1.83 M (-39.56%)